Shots:Biocon Biologics has expanded its strategic collaboration with Civica to commercialize Insulin Glargine in the USBiocon Biologics & Civica entered into a multi-year exclusive distributorship where Biocon will manufacture & supply Insulin Glargine, & Civica will handle its commercialization in the US under its own label, incl. the CalRx brand in CaliforniaNo…